Proteomics

Dataset Information

0

Mode of action studies for a novel anti-leishmania compound


ABSTRACT: We describe the development of a novel anti-leishmanial drug-like chemical series based on a pyrazolopyrimidine scaffold. The leading compound is efficacious in a mouse model of visceral leishmaniasis, and has suitable physicochemical, pharmacokinetic and toxicological properties for further development and has been declared a preclinical candidate. Detailed mode of action studies indicate that compounds from this series act principally by inhibiting the parasite protein kinases.

INSTRUMENT(S): LTQ Orbitrap Velos

ORGANISM(S): Leishmania Donovani

DISEASE(S): Visceral Leishmaniasis

SUBMITTER: Michael Urbaniak  

LAB HEAD: Ian H Gilbert

PROVIDER: PXD009711 | Pride | 2018-11-30

REPOSITORIES: Pride

Similar Datasets

2014-02-01 | E-GEOD-48394 | biostudies-arrayexpress
2008-06-26 | E-MEXP-1539 | biostudies-arrayexpress
2016-08-01 | E-GEOD-71572 | biostudies-arrayexpress
2013-04-18 | E-GEOD-46162 | biostudies-arrayexpress
2010-05-22 | E-GEOD-18049 | biostudies-arrayexpress
2009-10-15 | E-GEOD-18554 | biostudies-arrayexpress
2013-04-18 | E-GEOD-46160 | biostudies-arrayexpress
2019-10-22 | PXD013488 | Pride
2023-11-01 | E-MTAB-12377 | biostudies-arrayexpress
2011-12-15 | E-GEOD-26256 | biostudies-arrayexpress